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Abstract
The present study explores the methods to determine human in vivo protein-
specific myofibrillar and collagenous connective tissue protein fractional
synthesis and breakdown rates. We found that in human myofibrillar proteins,
the protein-bound tracer disappearance method to determine the protein
fractional breakdown rate (FBR) (via 2H2O ingestion, endogenous labeling of
2H-alanine that is incorporated into proteins, and FBR quantified by its
disappearance from these proteins) has a comparable intrasubject reproducibil-
ity (range: 0.09–53.5%) as the established direct-essential amino acid, here
L-ring-13C6-phenylalanine, incorporation method to determine the muscle
protein fractional synthesis rate (FSR) (range: 2.8–56.2%). Further, the
determination of the protein breakdown in a protein structure with complex
post-translational processing and maturation, exemplified by human tendon
tissue, was not achieved in this experimentation, but more investigation is
encouraged to reveal the possibility. Finally, we found that muscle protein FBR
measured with an essential amino acid tracer prelabeling is inappropriate
presumably because of significant and prolonged intracellular recycling, which
also may become a significant limitation for determination of the myofibrillar
FSR when repeated infusion trials are completed in the same participants.
Introduction
The study of protein mass adaptation in whole body and
limb, in structures such as skeletal muscle and tendons,
and in various tissues and organs during health and disease
requires knowledge of the dynamics of protein turnover
(Garlick and Millward 1972; Millward et al. 1975; Young
1976; Matthews 1993). Thus, valid measures of protein
turnover involving both protein synthesis and breakdown
rates are mandatory. These measures are possible with the
use of stable isotopically labeled amino acid tracers. Using
such tracers, many approaches exist and care must be taken
with designing complex studies involving repeated tracer
exposure in, for example, cross-over studies.
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Two distinct tracer principles, the tracer dilution and
the direct incorporation, form the basis for existing
approaches to measure protein turnover rates. The tracer
dilution principle measures amino acid tracer dilution in
whole body (1-pool) or across a tissue-bed with sampling
of arterial and tissue-draining venous blood (2-pools) or
within pools closer to a tissue of interest by the addition
of sampling sites: the interstitial compartment by micro-
dialysis and the intracellular compartment by obtaining
biopsies (Barrett et al. 1987; Biolo et al. 1992; Gore et al.
2007). The tracer dilution method is a direct measure of
amino acid flux rates in and out of pools, hence allows a
concomitant estimate of both protein synthesis and
breakdown rates, and is frequently applied in muscle
physiological research (Barrett et al. 1987; Gelfand and
Barrett 1987; Biolo et al. 1994). However, the tracer dilu-
tion principle is protein unspecific and thus limited when
the purpose is to investigate the changes in protein turn-
over of a specific protein or protein group. In this case,
the alternative option, the direct incorporation method
also known as the amino acid tracer precursor–product
method (Garlick et al. 1973; Toffolo et al. 1993), allows a
direct measure of a fraction of proteins or even single
protein synthesis rates. This, however, can be limited by
the requirement of sampling the proteins of interest, and
it should be in sufficient quantities (e.g., Balagopal 1998;
Jaleel et al. 2008). Basically, the approach is that protein
synthesizing cells are exposed to known amounts of an
amino acid tracer and by measuring the abundance of
tracer being incorporated into the protein between two
time points (Garlick et al. 1975; Golden and Waterlow
1977), a direct average protein synthesis rate (the frac-
tional synthesis rate (FSR)) is determined as a gross mean
between the two time points. A protein-specific approach
– comparable to the FSR method – to determine the pro-
tein degradation is also warranted (Chinkes 2005; Holm
and Kjaer 2010). We previously presented a method
where the rate of loss of protein-bound tracer is followed
as a reflection of the fractional breakdown rate (FBR)
determined exactly on the same protein pools as used for
assessing the FSR (Holm et al. 2013). The principle of
this prelabeling approach is to first label proteins of inter-
est by administering deuterated water (2H2O). Deuterium
atoms will be transferred from water to several metabo-
lites via various metabolic pathways (Neese et al. 2002;
Strawford et al. 2004; Busch et al. 2006). Deuterium-la-
beled amino acids are incorporated into proteins during
de novo synthesis, thus labeling the proteins. Hereafter, a
period of time has to pass to allow 2H2O as the label
donor to disappear from the precursor pool to secure no
further re-incorporation of deuterium-labeled amino acids
into protein. Once the 2H2O enrichment has disappeared,
the loss of labeled amino acids from the protein pool will
be a consequence of breakdown of the labeled proteins
herein. Under the assumption that the protein pool size
is not changing, the rate of disappearance of labeled pro-
teins is an estimate of the protein FBR (Holm et al.
2013).
The proteins isolated for assessment of FSR and FBR
approaches are similar, assuming the same protocol is
used, and therefore, a comparison of the kinetic rates as
well as knowledge on and a comparison of the inter- and
intrasubject variation of the two methods are of interest
for future applications. Further, fundamental biological
differences are apparent between the conditions under
which the protein-bound tracer abundances are changing
during the two approaches. While the FSR is based on
measuring the momentary (minutes and few hours)
increase in abundance of the amino acid tracer during its
immediate exposure to the proteins of interest, the FBR is
based on the disappearance of protein-bound tracers,
which were incorporated several days and weeks previ-
ously. Hence, although the proteins for both FSR and
FBR determination are present in the same sample, the
pools of proteins being labeled and, hence, the pool of
proteins founding the “proteins of interest” in the two
approaches are for certain different in age. For protein
structures with complex post-translational processing
before being fully matured and functional such as tendon
collagen proteins (Canty and Kadler 2002), the difference
between FSR and FBR measurements may be even more
pronounced. Therefore, the tendon collagen protein is a
suitable model to investigate the impact of protein matu-
ration processing on the disappearance of incorporated
tracer from a complex protein structure. In the interest of
applicability, the extensive (60–80 days) protein prelabel-
ing and precursor de-labeling period is a practical chal-
lenge especially in human studies. It makes it impossible
to apply under “acute” conditions and during standard-
ized diseased conditions when more than two months
have to pass from planning to actual measurement. In
order to overcome this time gap, we investigate whether a
classic essential amino acid tracer (exemplified by 15N-
phenylalanine, having a much higher turnover rate than
water (Holm et al. 2014)) can be used for labeling the
proteins of interest with the purpose of measuring the
FBR in a similar experimental setup as that with the
deuterated nonessential amino acid method.
The present study was designed to explore the methods
of measuring the protein-specific FSR and FBR, and the
following purposes were defined: (1) to compare mea-
sures of the FSR and FBR on the same subjects and assess
the inter- and intrasubject variation; (2) to determine the
FBR of a tendinous collagen tissue that is known to con-
tain protein pools with very distinct protein turnover
rates and undergo extensive post-translational maturation
2019 | Vol. 7 | Iss. 17 | e14143
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processes; (3) to investigate whether the FBR protocol can
be shortened by the use of a classic essential amino acid
tracer to prelabel proteins and determine protein FBR;
and 4) to explore in vivo essential amino acid recycling
issues both in the context of measuring FSR and FBR.
Method
Study 1
Subject recruitment and ethical approval
Nine healthy and moderately physically active males were
recruited through advertisements at the webpage www.for
sogsperson.dk. Their characteristics were as follows: age:
22.4  2.1 years (mean  SD); body mass index (BMI):
23.0  3.0 kgm2; and lean body mass (LBM):
61.7  8.6 kg, and they were all recruited as being tracer
na€ıve, that is, never having received any stable isotopically
labeled compounds. A written informed consent was
obtained before they were enrolled in the experiment that
was approved by the Copenhagen Ethics Committee (H-
1-2010-007) and conformed to the code of the Helsinki
Declaration.
In this study, we aimed at determining the reproducibil-
ity of the deuterated water-based FBR measurement
described previously (Holm et al. 2013) (Experiment 1)
and comparing the values and their reproducibility with
the comparable FSR values (Experiment 2), as well as test-
ing whether the prelabeled FBR method can be performed
with the use of a classic essential amino acid tracer (here
15N-phenylalanine) (Experiment 3). Part of the data on a
subset of the subjects (N = 7) are reported in a previous
paper (Holm et al. 2014).
The overall design of Study 1 is shown in Figure 1A.
Upon inclusion and before starting the experiments, all
subjects had their whole-body lean mass (LBM) determined
from a dual-energy X-ray absorptiometry scanning (Lunar
DPX, Madison, MI; software version 3.6z). At Day 0, sub-
jects drank a total volume of 5.25 mLkg LBM1 of 99%
2H2O, which was diluted 1:1 with tap water and provided
in 3–4 boluses over a 2-h period. Blood samples were taken
before the deuterated water bolus was given and at days 7,
14, 21, 42, 70, 80, and 94 hereafter to determine the deu-
terium enrichment of plasma-free alanine. At Day 70, the
subjects arrived to the laboratory in the overnight fasted
state, had a venous catheter inserted in the antecubital vein
in each arm, had a fasting blood sample drawn, and
received a 6-h primed (32 lmolkg LBM1) continuous
(32 lmolkg LBM1kg1) infusion of 15N-phenylalanine.
Hereafter, blood samples were taken at 1, 2, 4, and 6 h to
determine tracer enrichment. This trial was conducted to
label the slow turning over muscle proteins with
15N-pheylalanine, and subjects were therefore also given
hourly drinks (0, 1, 2, 3, 4, 5 h) containing 2.5 g L-leucine
and 10 g maltodextrin (both Fagron, GmbH & Co.KG,
Barsb€uttel, Germany) to enhance protein synthesis improv-
ing the incorporation of phenylalanine tracer into skeletal
muscle during the infusion trial. The time elapse for tracer
infusion prior to FBR assessment was chosen as a trade-off
to allow a high abundance of protein-bound tracer and
estimated adequate time to achieve negligible levels of free
tracer in the blood and intramyocellular pools also taking
the recycling from fast turning over proteins into account
(Kaufman 1999). At Day 80, the subjects reported to the
laboratory and had a muscle biopsy taken from each leg
using standard procedures under local anesthesia (lidocaine
1%) aiming at determining the muscle protein-bound
abundances of 2H-alanine and 15N-phenylalanine and
venous blood sample to determine the enrichments of the
same two tracers in the plasma. Finally, at Day 94, the sub-
jects reported to the laboratory to have another muscle
biopsy taken in order to assess the disappearance rate of
2H-alanine and 15N-phenylalanine. In addition, on Day 94,
a 6-h infusion trial was conducted. Therefore, subjects were
instructed not to perform any strenuous exercise on 3 days
prior to Day 94 and they arrived to the laboratory in the
morning by car or public transportation and were in the
overnight fasted state. After placing two catheters in the
antecubital veins of each arm and drawing a basal blood
sample, the flood-prime was given as a total of 1665 mg
phenylalanine: 1480 mg unlabeled (8.97 mmol) and
185 mg labeled [ring-13C6]-phenylalanine (1.08 mmol) fol-
lowed by a continuous infusion (8 lmolkg LBM1h1) of
[ring-13C6]-phenylalanine. Bilateral vastus lateralis muscle
biopsies were obtained after 120 and 360 min, and blood
samples were collected throughout the trial. Using the
change in incorporation of phenylalanine, between 120 and
360 min, we determined the myofibrillar protein synthesis
rate in the vastus lateralis muscles from both legs (Fig. 1B).
From the bilateral muscle biopsies obtained at days 80
and 94, we analyzed samples for abundances of [2H]-ala-
nine and [15N]-phenylalanine required for calculating the
FBR of myofibrillar proteins based on the two tracer
administration approaches. Further, from samples
obtained on Day 94 during the ring-13C6-phenylalanine
tracer experiment, we analyzed samples from subjects in
the basal, overnight fasted state to calculate the myofibril-
lar protein FSR using the precursor–product approach.
Study 2
Subject recruitment and ethical approval
Thirteen healthy and sedentary elderly males (age:
68.8  6.5 years [mean  SD]; body mass index [BMI]:
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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24.9  1.8 kgm2, lean body mass [LBM]: 57.2  4.7 kg)
were recruited through newspaper advertisements. They
were all recruited as being tracer na€ıve, and the written
informed consent was obtained before subjects were
enrolled in the experiment that were approved by the
Copenhagen Ethics Committee (H-1-2010-007) and con-
formed to the code of the Helsinki Declaration.
Subjects were enrolled in an experiment aiming at
determining the tendon connective tissue protein as well
as the muscle protein FSR before and after a 2-week per-
iod of lower limb immobilization (Dideriksen et al.
2016). Further, deuterated water was provided to the sub-
jects 70 days prior to the immobilization-retraining pro-
tocol to determine the myofibrillar protein FBR over the
period of immobilization as well as during the retraining
period (Dideriksen et al., unpublished). Upon inclusion,
subjects had their whole-body lean mass (LBM) deter-
mined from a dual-energy X-ray absorptiometry scanning
Figure 1. Overview of design of Study 1, experiments 1–3, Study 2, and Study 3. (A) Study 1: The experimental protocol lasted 94 days.
Deuterated water was administered on Day 0 as 3–4 boluses over a 2-h period, and 15N-phenylalanine was infused over 6 h on Day 70,
respectively. At days 80 and 94, muscle biopsies were obtained from the vasti lateralis of both legs on study participants to determine the
disappearance rate of 2H-alanine and 15N-phenylalanine tracers to calculate the FBR. (B) Study 1, Experiment 2. On Day 94 in Study 1, an
infusion of ring-13C6-phenylalanine was given to assess the fractional synthesis rate, FSR, in both legs. (C) Study 2: Determining the
incorporation and disappearance of 2H-alanine in patella tendon indispensable protein. Deuterated water was administered on Day 0, and
biopsies were obtained from one leg (normally active) at Day 70 and the other leg (after 14 days of immobilization) at Day 86. D) Study 3:
Four trials infusing ring-13C6-phenylalanine were conducted separated by 7–10 days and four muscle biopsies obtained in each trial to
investigate the incorporation of tracer in muscle proteins. Abbreviations: B: tissue biopsy. LBM: lean body mass. Immob: unilateral cast
immobilization. RT: resistance training bout. SUPPL: Leu/branched chain amino acids/essential amino acids/placebo supplement.
2019 | Vol. 7 | Iss. 17 | e14143
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(Lunar DPX, Madison, MI; software version 3.6z). At Day
0, subjects drank a total volume of 5.25 mLkg LBM1 of
99% 2H2O, which was diluted 1:1 with tap water and
provided in 2–3 boluses over a 1-h period. At days 70
and 86, the subjects arrived at the laboratory by car or
public transportation after an overnight fast and had a
patella tendon biopsy taken using a disposable 14-G nee-
dle (Bard Magnum Biopsy Instrument, C.R. Bard Inc.,
Covington, Kentucky) under local anesthesia (lidocaine
1%). The nonimmobilized leg was biopsied at Day 70
and the immobilized leg at Day 86 during an amino acid
tracer infusion protocol to assess the fractional synthesis
rate of tendon connective tissue proteins (Dideriksen
et al. 2017). Hence, the tendon samples prepared for
amino acid tracer abundance were also analyzed for pro-
tein-bound abundances of 2H-alanine. On both days, sub-
jects were instructed to refrain from alcohol and
strenuous physical activity and to follow their normal eat-
ing pattern 72 h prior to the tendon biopsy sampling.
Furthermore, no intake of caffeine was allowed 24 h
before the tendon biopsy sampling.
Study 3
Subject recruitment and ethical approval
Eight healthy males who were accustomed to strength
training (age: 26.5  65.6 years [mean  SD]; body
mass: 83.5  8.3 kg, height: 180.5  8.4 cm) were
recruited through adverts at local gyms and at www.gih.se
. They were all recruited as being tracer na€ıve, and the
written informed consent was obtained before subjects
were enrolled in the experiment that were approved by
the Regional Ethical Review Board in Stockholm (Dnr
2014/96-31/2) and conformed to the code of the Helsinki
Declaration.
The main purpose of this study was to determine mus-
cle protein FSR during 3-h recovery following leg press
exercise and ingestion of leucine, all three branched-chain
amino acid, a mixture of essential amino acids, or fla-
vored water acting as a placebo supplement (Moberg
et al. 2016). The supplements were given to the subjects
in a counter-balanced order, and the trials were separated
by 7–10 days. The FSR of muscle protein was measured
using L-ring-13C6-phenylalanine infusion to determine
FSR following resistance exercise. Prior to the series of
four trials, all subjects had gone through medical screen-
ing and maximal strength testing and completed three
sessions of heavy leg press exercise for training customiza-
tion.
On the day of the trials, subjects reported to the labora-
tory at 6 AM following an overnight fast. Subjects were
instructed to refrain from all types of vigorous physical
activity and to eat the same diet during the 2 days prior to
the experiments. Upon arrival, subjects were instructed to
lie down for insertion of venous catheters in the antecu-
bital vein of both arms. After a baseline blood sample was
drawn, a primed constant infusion of L-ring-13C6-pheny-
lalanine (prime 2 lmolkg1; 0.05 lmolkg1min1,
Cambridge Isotope Laboratories, Danvers, MA) was initi-
ated and continued thereafter for the duration of the
experiment (~6 h). A first vastus lateralis muscle biopsy
was collected after two hours of tracer infusion, at rest,
using a Weil-Blakesley conchotome (AB Wisex, M€olndal,
Sweden) under local anesthesia (Henriksson 1979). Follow-
ing the baseline muscle biopsy, subjects performed a ses-
sion of heavy leg press exercise that lasted approximately
50 min. The amino acid supplements were consumed dur-
ing as well as after exercise and administered in a random-
ized order. Immediately after exercise (time (0) zero at
Fig. 1D), a second muscle biopsy was collected, followed
by a third and fourth after 90 and 180 min of recovery,
respectively. All biopsies were taken from alternating legs
(i.e., 1st; right, 2nd; left, 3rd; right, 4th; left) all from a new
incision approximately 2 cm proximal to the previous one.
During the second trial, the biopsies were collected 2 cm
medial to the previous ones. In the third and fourth trials,
the biopsies were collected in the same manner but 2 cm
proximal to the previous ones. The muscle tissue was
rapidly blotted free from blood, frozen in liquid nitrogen,
and subsequently stored in 80°C. Muscle samples were
then lyophilized and meticulously dissected clean from
blood and connective tissue under a light microscope, leav-
ing only very small intact bundles of fibers that were mixed
to obtain a highly homogenous sample free of contaminat-
ing tissue
Analyses
Plasma phenylalanine tracer enrichment and concentra-
tions and alanine tracer enrichments were determined by
using 200 lL plasma, added a known amount of
[U-13C9]-phenylalanine for use as an internal standard,
acidified with 1 mL 50% acetic acid, and poured over
resin columns preconditioned with 1 mL 50% acetic acid.
After five washes with Millipore water two times, 1 mL
NH4OH was added to the resin columns and the eluent
collected. After being dried down under a stream of
nitrogen, the purified amino acids were derivatized using
MtBSTFA + 1% tBDMCS (Regis Technologies, Inc., Mor-
ton Grove, IL) and acetonitrile, volume relation 1:1. The
tBDMS derivatives of the amino acids were analyzed by
tandem mass spectrometry using a Thermo Scientific,
TSQ Quantum GC-MS/MS (San Jose, CA), under elec-
tron ionization mode. The derivatives were separated on
a 30 m CP Sil-8 CB capillary column (ChromPack,
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Varian, Palo Alto, CA) using PTV mode injection of
1 lL. The 13C and 15N enrichments of the phenylalanine
and 2H-alanine tracers were measured by GC-MS/MS by
monitoring the fragments of the [M-COOtBDMS]+
parent ions of m/z [234–243] and [158–159] for pheny-
lalanine and alanine, respectively, in the neutral loss mode
[-56].
Muscle specimens from Study 1 of ~20 mg wet weight
were homogenized (Fastprep, 120A-230, Thermo Savant,
Holbrook, NY, USA) for 2 9 45 sec in 1.5 mL ice-cold
Millipore saline water. After a spin (5500 g, 10 min,
4°C), the supernatant was transferred to new cooled vials
containing 1.5 mL 100% acetic acid, vortexed, and
poured over resin columns preconditioned with 1 mL
50% acetic acid. The amino acids were then purified over
resin columns and derivatized as their tBDMS derivatives
as described for the plasma free amino acids. The myofib-
rillar protein fraction was isolated from the remaining
protein pellet by adding 1 mL of a homogenization buffer
(Tris 0.02 molL1 [pH 7.4], NaCl 0.15 molL1, EDTA
2 mmolL1, Triton-X 100 0.5%, sucrose 0.25 molL1),
homogenizing 2 9 45 sec and following the procedures
reported previously (Holm et al. 2014). The myofibrillar
protein pellet was hydrolyzed overnight in 1 ml of
6 molL1 HCl at 110°C. The liberated amino acids were
purified over cation exchange resin columns and deriva-
tized as their N-acetyl-n-propyl (NAP) esters for determi-
nation of the 2H-alanine and 13C- and 15N-phenylalanine
abundances.
Tendon specimens obtained in Study 2 were prepared
as previously described (Dideriksen et al. 2013). Briefly,
connective tissue collagen protein was isolated from ten-
don biopsies by homogenization first 5 9 15 s in 1 mL
of homogenization buffer (Tris 0.02 molL1, pH 7.4,
0.15 molL1 NaCl, 2 mmolL1 EDTA, and 0.05% Tri-
ton-X 100), left for 2 h, and spun (1600 g, 20 min, 4°C).
Hereafter, 1 mL of high-salt solution (0.7 molL1 KCl)
was added to the pellet, which was left overnight at 4°C.
After a spin (1600 g, 20 min, 4°C), 1 mL of KCl was
added to the pellet, which was homogenized and left for
2 h. After spinning (1600 g, 20 min, 4°C), the pellet was
washed once in 70% ethanol and hydrolyzed overnight in
1 ml of 6 molL1 HCl at 110°C. The liberated amino
acids were purified over cation exchange resin columns
and derivatized as their N-acetyl-n-propyl (NAP) esters to
determine the abundance of 2H-alanine.
In Study 3, the myofibrillar protein tracer enrichments
were determined from 10 mg of lyophilized muscle tissue.
Homogenization was performed in ice-cold buffer
(2 mmolL1 HEPES (pH 7.4), 1 mmolL1 EDTA,
5 mmolL1 EGTA, 10 mmolL1 MgCl2, 50 mmolL1
b-glycerophosphate, 1% TritonX-100, 1 mmolL1
Na3VO4, 2 mmolL1 dithiothreitol, 1% phosphatase
inhibitor cocktail [Sigma P-2850], and 1% [w/w] Halt
Protease Inhibitor Cocktail [Thermo Scientific, Rock-
ford]) utilizing a BulletBlender (NextAdvance, New
York). The homogenates obtained were rotated for
30 min at 4°C and subsequently centrifuged at 10,000g
for 10 min at 4°C. The resulting pellet was collected and
washed once with 500 lL purified H2O, then dissolved in
1 ml homogenization buffer (see above), and centrifuged
at 1600g for 20 min at 4°C. The supernatant was dis-
carded, and the pellet containing myofibrillar protein was
lyophilized prior to hydrolysis.
All NAP-derivatized samples were analyzed on the
IRMS equipment. For 13C and 15N abundances in pheny-
lalanine, the GC-combustion system was used as
described previously (Holm et al. 2014). The 2H-alanine
abundances were determined on the GC-temperature con-
version setting following previously described procedures
(Holm et al. 2013).
Calculations
All enrichments were determined as the tracer-to-tracee
ratio by subtracting the isotope ratio of a background
sample from the isotope ratio of the labeled samples.
The protein fractional synthesis rate was determined by
using the precursor–product approach: FSR = Δprotein-
bound tracer 9 Eprecursor
1 9 incorporation time1. The
myofibrillar protein-bound tracer abundance over the
course of a 4-h period (120–360 min in study 1 and 2)
or a 3-h period (0–180 min, study 3) was determined.
The muscle free tracer enrichment was used as a surrogate
measure of the precursor enrichment.
The protein fractional breakdown rate was determined
using the procedure described previously (Holm et al.
2013). Basically, loss of 2H-alanine over time from two
protein samples was as estimate of the rate of protein
degradation. It was determined by log transforming the
measured enrichments of protein-bound tracer at two
protein samples and the slope of the line made by the
two samples were the rate constant.
Statistics
When more than two sampling points are reported within
one group, a one-way ANOVA with repeated measures
was used, whereas a two-way ANOVA was applied to
compare multiple sampling points in two or more
groups. The myofibrillar FSR and FBR values from left
and right legs were set up assuming sphericity, whereas
tendon and myofibrillar enrichments over prolonged per-
iod of time were set up not to assume sphericity. When
significant overall effects, post hoc Holm–Sidak tests were
performed, and when appropriate, t-tests were applied to
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compare only two data points. The statistical software
Prism 7.04 (GraphPad, CA, USA) was used for all statisti-
cal tests. Data are reported as mean  standard error of
mean (unless otherwise stated), and a P-level below 0.05
was considered as significant.
Results
Study 1, Experiment 1: Plasma-free and
muscle protein-bound 2H-alanine
enrichment
Intake of 2H2O resulted in an
2H-alanine enrichment in
plasma at Day 7 of 0.27  0.02%, which decreased with a
rate of 6.5  0.9%d1 to an enrichment not significantly
different from zero at days 70, 80, and 94 (Fig. 2, symbol
♦ marked with #). Myofibrillar protein-bound 2H-alanine
enrichment as a mean of the two legs was
0.040  0.005% and 0.034  0.004% at days 80 and 94,
respectively (Fig. 2, symbol ▲), and the intra-individual
variation (difference between the measures in each leg
related to the mean of the samples taken concomitant
from the vastus lateralis from each leg) at days 80 and 94
was 2.2  4.1% and 1.6  2.6%, respectively.
Study 1, Experiments 1 and 2: Myofibrillar
protein turnover rates
After intake of deuterated water on Day 0, the myofibril-
lar protein FBR in vasti lateralis muscles as a gross mean
from Day 80 to Day 94 was calculated to
0.056  0.004%h1 and 0.057  0.007%h1 for left and
right legs, respectively (Fig. 3, P = 0.81). The intra-indi-
vidual variation was 0.5  12.0% (0.09–53.5%) (calcu-
lated as the difference between paired measurements
divided by the mean of the two measurements), and
interindividual coefficient of variation of the mean
between the legs was 22%.
For comparison, we determined, in Experiment 2, the
overnight fasted and resting myofibrillar protein fractional
synthesis rates (FSRs) also in the vasti lateralis muscles of
both legs and it was 0.079  0.015%h1 and
0.087  0.011%h1 for left and right legs, respectively
(Fig. 4, P = 0.27). The intra-individual variation was
17.5  10.7% (2.8–56.2%), and the interindividual coeffi-
cient of variation of the mean between the legs was 43%.
A comparison of the two protein turnover kinetics
revealed that the FSRs in average were 1.48  0.19 fold
higher than the paired FBR rates (Fig. 5, P < 0.01).
Study 2: Patella tendon connective tissue
protein 2H-alanine enrichment
In Study 2, another group of participants had a patella
tendon biopsy taken from one leg at Day 70 and the
other leg at Day 86; after this, latter leg had been immo-
bilized for 14 days. The 2H-alanine enrichments in the
Figure 2. Experiment 1, administration of 2H2O and the
subsequent enrichment of 2H-alanine. After intake of deuterated
water on Day 0, the deuterium atoms are transferred to numerous
metabolites and alanine receives up to four enzyme-dependent
deuterium atoms allowing high analytical sensitivity on amino acid
enrichment. At days 7, 14, 21, 42, 70, 80, and 94, plasma samples
were obtained and symbol ♦ shows the enrichments. # denotes
plasma enrichments not different from zero. At days 80 and 94,
muscle biopsies were obtained bilaterally and symbol ▲ shows
myofibrillar protein-bound 2H-alanine as a mean from both legs
from all subjects at the two separate days. * denotes significantly
different enrichment in muscle protein-bound 2H-alanine. Symbols
are mean and bars SEM.
Figure 3. Experiment 1, administration of 2H2O and the
measurement of 2H-alanine-based myofibrillar protein fractional
breakdown rate. Based on symbols ▲ on Figure 2, the FBR was
determined as an average over a 14-day period from Day 80 to
Day 94 after intake of deuterated water. For each of the vastus
lateralis muscles in both legs, the FBR was determined of each
subject and plotted as the left and right leg connected with a line
(P = 0.81).
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patella tendon connective tissue protein is depicted in
Figure 6. There was a significant (P < 0.05) enrichment
(>zero) at both days 70 and 86, however, with no differ-
ence between the 2 days (P = 0.55). Since the enrich-
ments were not different at the 2 days, we calculated the
intra-individual variation as the difference between the
enrichments divided by the mean enrichment to be
50.0  60.4% (1–622%) and the interindividual coeffi-
cient of variation at days 70 and 86 of 79% and 121%,
respectively.
Study 1, Experiment 3: Plasma-free and
muscle protein-bound 15N-phenylalanine
In Study 1, the subjects were given an infusion of
15N-phenylalanine at Day 70, which resulted in a
15N-phenylalanine enrichment in plasma of 36.9  2.0%
and 47.1  1.9% at 1 and 6 h, respectively (Fig. 7,
symbols ♦), which decreased to 4.97  1.63% and
1.36  0.60% at days 80 and 94, respectively (Fig. 7,
symbol ▲). The mean (one muscle biopsy from each leg
at each time point) muscle myofibrillar protein-bound
15N-phenylalanine enrichment was 0.145  0.005% and
0.136  0.004% at days 80 and 94, respectively
(P < 0.05) (Fig. 7, symbol ★).
Study 3: Increasing abundance of ring-13C6-
phenylalanine in myofibrillar protein with
repeated infusions
The myofibrillar protein tracer enrichment in the 16 mus-
cle biopsies collected during the four separate trials for all
subjects is depicted in Figure 8. During the first trial,
there is an increase throughout the experiment and the
individual variation is relatively small. However, during
the second, third, and fourth trials, the variation in
enrichment increases progressively and, in some cases,
this results in negative delta values and hence negative
FSR values. Particularly during the third and fourth trials,
both very large delta increases and decreases were noted
over time, particularly in the latter. The mean delta tra-
cer-to-tracee ratio for all biopsies in the different trials
Figure 4. Experiment 2, infusion of ring-13C6-phenylalanine and
the measurement of the myofibrillar protein fractional synthesis
rate. Based on the rate of incorporation of ring-13C6-phenylalanine
over a 4- to 5-h infusion trial on Day 94, the myofibrillar protein
fractional synthesis rates were calculated in each of the vastus
lateralis muscles in the left and right legs of each subject and
paired values are connected with a line (P = 0.27).
Figure 5. Experiments 1 and 2: comparison of the myofibrillar FSR
and FBR values. Paired values of myofibrillar FSR and FBR for each
of the research participants are connected with a line and appear
pairwise, one set of values for each leg obtained at the same time.
A two-way ANOVA test reveal difference between FSR and FBR
values (P < 0.01), with a 4-h resting and fasting myofibrillar FSR
being 1.48  0.19 fold higher than the comparable 14-d gross
mean of myofibrillar FBR.
Figure 6. Study 2: administration of 2H2O and
2H-alanine
enrichments in patella tendon tissue proteins after 70 and 86 days.
Deuterated water was provided a group of elderly males enrolled in
a clinical trial investigating skeletal muscle and tendon tissue
adaptation to immobilization. Patella tendon biopsies were
obtained from one leg at Day 70 and from the contralateral leg at
Day 86 (after 14 days of immobilization). 2H-alanine enrichments
from each leg are depicted, and within subjects, enrichments are
connected with a line (P = 0.55).
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was 0.0004  0.00019 (mean  SD) for the first,
0.0004  0.00068 for the second, 0.0004  0.00082 for
the third, and 0.0004  0.00180 for the fourth, noticeably
illustrating the increase in variation in tracer enrichment
with repeated trials.
Discussion
In this study, we started by comparing the variations of
the two methods to determine the protein-specific turn-
over rates in skeletal muscle, namely the disappearance
rate of protein-bound deuterated alanine as an estimate
of the fractional breakdown rate (FBR) versus the direct
incorporation rate of carbon-13 phenylalanine in the sim-
ilar protein pool.
We found no statistical difference between the legs for
any of the two rates and the intrasubject variation (left
and right legs) was within the same range: 0.09–53.5% for
FBR and 2.8–56.2% for FSR. We do neither ascribe activ-
ity-related side-specific differences nor different fiber-type
compositions (Mittendorfer et al. 2005) to be causing the
surprisingly large intrasubject variation. The included par-
ticipants were recruited as being recreationally active with
no specific preferences for physical activities or sports.
Also, laboratory processing of muscle tissue and analysis
cannot have caused the largest observed variation. There-
fore, we suggest that the variation between legs must be
caused by actual local intramuscular biological/physiologi-
cal differences; for example, distinct anatomical locations
within the muscle have different protein turnover rates,
maybe due to differences in recruitment pattern; and dif-
ferent areas within the muscle have different blood perfu-
sion.
The between-subject coefficient of variation of the FBR
measurement of 22% was somewhat smaller than that of
the FSR measurement, 43%. The immediate interpretation
of this difference is that the synthesis rates are subject to
larger fluctuations than the breakdown rates (Phillips
et al. 2009) although it lacks evidence. In support of this
notion, the conditions around the FSR trial (measured
over minutes to hours) are easier to control and stan-
dardize in opposed to the FBR, which is an average over
days. We cannot reject that a more thorough standardiza-
tion prior to the FSR measurement period potentially
could decrease the interindividual variation for this mea-
sure, though would require that research participant met
into the laboratory one or more days prior to the experi-
ment.
Of relevance to discuss is also the numerical difference
between the FBR and FSRs, with FBR 14d gross average
FBR being 77  10% lower than the acute 6-h average
FSR in the resting, fasting condition, which would be
expected to be an underestimation of the gross daily
Figure 7. Experiment 3, infusion of 15N-phenylalanine and
enrichment in plasma and in skeletal muscle. On Day 70, subjects
in Study 1 received a 6-h continuous infusion containing a high
amount of 15N-phenylalanine and plasma enrichments are shown
after 1, 2, 4, and 6 h of infusion (symbol ♦). The subjects went
home after the 6-h infusion at Day 70 and came in again at days
80 and 94 (i.e., 10 and 24 days after the infusion) and had a blood
sample drawn and muscle biopsies taken (same as for Experiment
1). Symbol ▲ denotes plasma 15N-phenylalanine enrichments at
days 80 and 94, and symbol ★ denotes means of myofibrillar
protein-bound 15N-phenylalanine enrichment at days 80 and 94.
Symbols are mean and bars SEM.
Figure 8. Individual values of L-[ring-13C6]-phenylalanine
abundance in the myofibrillar protein fraction and calculated FSR in
four trials on the same subjects. (A) The data on the Y-axis is
13C6-phenylalanine tracer abundance measured by GC-C-IRMS in
16 biopsies from each of the eight subjects. Biopsy numbers 1, 5,
9, and 13 were taken fasted at rest in the morning after a primed
2-h infusion period; biopsy numbers 2, 6, 10, and 14 were taken
immediately after leg press exercise and supplement intake
approximately 60 min after the previous one (defining time zero);
biopsy numbers 3, 7, 11, and 15 were taken after 90 min of
recovery and biopsy numbers 4, 8, 12, and 16 after 180 min of
recovery. (B) Myofibrillar protein FSR during the 3-h
postexercise/supplement period in the four trials, that is, calculated
between 0 (zero)- and 180-min biopsies. The intracellular
13C6- phenylalanine enrichment was used as precursor pool in the
calculations. Each trial was separated by 7–10 days.
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average synthesis because of the absence of muscle activity
and nutrients (Holm et al. 2010). Further, had the partic-
ipants been heavily physically active like those in Study 3,
the numerical turnover rates and the differences between
FSR and FBR might have been different. Further, we iso-
late the same myofibrillar proteins, but the proteins with
tracer bound in the prelabeling FBR protocol and with
tracer incorporated during the immediate exposure in the
FSR protocol may diverge in type, age, and maturation
stage and hence diverge in turnover rate. The numerical
deviation between the two rates must therefore be
ascribed to the methodological differences rather than
physiology. Hence, we argue that the FBR and FSR are
not numerically directly comparable and must not be
used to extrapolate to the net balance.
We continued our exploration of tracer data originating
from a protein pool undergoing a complex post-transla-
tional maturation process (exemplified by human tendi-
nous tissue). Some proteins are synthesized as preproteins,
from which pool only a fraction is further processed and
matured into a functional matrix protein – for example,
the collagenous proteins (Babraj et al. 2002; Bechshoft
et al. 2017). When exposed acutely to tracer, which is the
condition in the FSR protocol, fast turning over proteins
within the isolated protein pool will incorporate tracer
quickly and will increase the gross tracer abundance in the
protein fraction above that of what slower turning over
proteins contribute with. This we illustrate by reporting
the abundance of 13C-labeled proline and hydroxyproline
in a pool of tendon proteins 2 h after a flood of 13C-pro-
line in two studies from our research group ((Hansen et al.
2009; Petersen et al. 2011), Table 1). While a marked
increase in 13C-proline appeared in the mixed tendinous
proteins within the 2-h protocol, no label appeared on the
hydroxyproline residues, which have the 13C-proline as
precursor but require time for the post-translational pro-
cessing of the precollagen protein. In contrast, the labeling
of these high turning over proteins will be absent in the
prelabeling FBR protocol. Due to their high turnover rate,
these proteins will degrade rather quickly. This means that
once the precursor enrichment has dropped to zero, these
proteins will be degraded and no longer contribute with
label to the pool of proteins at the time of FBR determina-
tion. Further, even if the protein(s) of interest undergoes a
complex post-translational modification process, the situa-
tion will be the same. To investigate the impact of this phe-
nomenon on the FBR assessment, we obtained patella
tendon biopsies over the course of a 16-day period 70 days
after intake of deuterated water and found similar tracer
enrichments at 70 and 86 days albeit with a huge variation
(Fig. 6). The turnover of structural collagenous tissue is
debated as acute measures of synthesis reveal rather high
turnover rates (e.g., Holm et al. 2014; Miller et al. 2005,
2007), whereas other prelabeling approaches reveal almost
no turnover in adult life (Heinemeier et al. 2013; Bechshoft
et al. 2017). Obviously, these data cannot both be true for
the same proteins. However, they most likely demonstrate
the existence of different pools of connective tissue pro-
teins that are present in the isolated protein pool, which is
supported by animal work (Bechshoft et al. 2017). In Fig-
ure 9, we illustrate the enrichment in pools of proteins
with different turnover rates and maturation processes as a
function of time. FSR and FBR values of tissues/protein
fractions with such complex nature should be interpreted
with caution, and the absolute values cannot be directly
compared. Again, one should be reminded that these data
just exemplify a methodological challenge, while the
numerical data are less important and may diverge depen-
dent of participant characteristic (age, physical activity
level, health state, etc.) and investigated condition (fasting,
activity level/immobilized, health state, etc.).
The third objective of the study was to investigate the
feasibility of using a classic essential amino acid tracer to
prelabel proteins for the determination of FBR with the
Table 1. Abundance of 13C-labeled proline and hydroxyproline in skin and patella tendon proteins
Skin protein
Patella tendon protein
Ref.BGrd REST EXC
Proline 1.0870  0.0015 1.0887  0.0018a 1.0886  0.0019a Hansen et al. (2009)
Hydroxyproline 1.0810  0.0034 1.0813  0.0036 1.0812  0.0034
Gross average
Proline 1.0890  0.0003 1.0928  0.0050 Petersen et al. (2011)
Hydroxyproline 1.0858  0.0003 1.0871  0.0060
From two studies (Hansen et al. 2009; Petersen et al. 2011), we present the abundances of 13C-proline and 13C-hydroxyproline in skin protein
from background samples of tracer virgins and in patella tendon protein 2 h after a flood with 13C-proline. The proline abundances were sig-
nificantly elevated in the patella tendon protein in both studies, top: two-way ANOVA, P = 0.0003, and a denotes different from background,
P < 0.01. Bottom: paired t-test, P = 0.003, whereas the abundances of 13C-hydroxyproline did not change as a result of the 13C-proline flood:
top: two-way ANOVA, P = 0.58 and bottom: paired t-test, P = 0.32. Values are mean  SD.
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main purpose to shorten the protocol and make it more
applicable. To study this, we exposed subjects in Study 1,
Experiment 3, with 15N-phenylalanine tracer 10 days
prior to the 14-day FBR measurement period. This proto-
col was based on a compromise between (1) least time
from tracer exposure to FBR measurement with the pur-
pose to shorten the experimental protocol and to obtain
as high analytical sensitivity as possible of the tracer
enrichments in the proteins of interest and (2) enough
time to allow the free tracer (phenylalanine) to disappear
based on the natural flux rates. Phenylalanine has a quick
clearance rate in human circulation (Holm et al. 2014),
half-life estimated in the range 60–120 min (Kaufman
1999). Therefore, 10 days should in theory be sufficient
time to allow infused free phenylalanine tracer to disap-
pear from the watery pools, become metabolized, and/or
incorporated into proteins. The rather high enrichment of
free phenylalanine tracer in the blood after 10 days (4%
at Day 80) and 24 days (1% at Day 94) (Fig. 7) reveals a
marked recycling. An equilibrium of tracer abundances
between extra- and intracellular pools must be assumed
at these points in time, and hence, a continuous incorpo-
ration of tracer will take place at the time of FBR mea-
surement, between days 80 and 94. The crucial
assumption of null precursor enrichment during the FBR
measurement period is thereby violated, and therefore,
the FBR cannot be determined in this experimental set-
ting used here. To investigate whether recycling would be
an issue, we looked into some unpublished data (Table 2
and Fig. 8). From eight tracer naive individuals, we
obtained tendon and skin biopsies before tracer exposure,
and from tendon again after 2 h after a flood with 13C-
proline, and again 40 days after the flood. The connective
tissue pellet was isolated, and the abundance of 13C-pro-
line was determined (Petersen et al. 2011). The results
reveal that 13C-proline is highly present at 2 h and
40 days after a flood (Table 2A). Similarly, in muscle
biopsies from an ongoing study (Bechshoeft et al. 2016),
we determined the 13C-phenylalanine abundances in the
myofibrillar protein fraction 12 month after a 6.5-h
primed, continuous infusion of L-ring-13C6-phenylalanine
and found that 33% of the tracer abundance found at the
end of the infusion trial was still present 12 month later
(Table 2B). In both situations, the essential amino acid
tracer abundance in the protein fractions is most likely a
combination of the presence of matured and functional
matrix proteins as well as newly synthesized proteins due
to intracellular recycling of the essential amino acid tra-
cer. Based on these data, however, we conclude that it is
very unlikely that it will be possible to use phenylalanine
tracer to determine the FBR using the prelabeling
approach.
To emphasize the impact of essential amino acid tracer
recycling in the pool of labeled proteins from the myofib-
rillar protein fraction, we report unpublished data from
the study by Moberg and colleagues (Moberg et al. 2016).
From Figure 8, it appears that the variation in tracer
abundance in the myofibrillar protein pool increases as a
function of repeated trials, which we argue is due to tra-
cer-recycling as a consequence of repeated tracer expo-
sures. In Study 3, we would like to point the attention to
the methodological phenomenon as we studied individu-
als in the recovery from resistance exercise and provided
different feeding (water, free amino acids), which are
interventions that most likely have impacted the numeri-
cal values. However, the resistance exercise was
Figure 9. Theoretical illustration of tracer enrichments in different pools of proteins during the FSR and FBR measurement periods. The
hatched line is the free amino acid tracer enrichment in the precursor pool. The slim line represents the enrichment of the protein-bound tracer
in fast turning over proteins, and the medium thick and thick lines represent enrichments of protein-bound tracers in medium and slow turning
over proteins. The double line is the pool of a slow turning over protein after it has been post-translationally modified, why it takes some time
before the label starts to appear herein. The FSR is a gross mean of the weighted average made up of the turnover rate and the relative
abundance of a protein in the pool. Tracee amino acids from slow turning over proteins will dilute the isotope ratio measurement and decrease
the enrichment. At the time of FBR determination, all fast turning over proteins have lost their label and only proteins with slow turnover will
still be labeled. Hence, the FBR determination may be a measure of proteins with a more homogenous turnover rate.
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standardized across trials and the feeding regimens were
randomized between trials. Further, muscle biopsies were
obtained from both legs, alternating within each trial,
which we showed in Study 1 add some variability, though
evenly across all trials.
In conclusion, the present study demonstrates that the
measurement of human myofibrillar protein fractional
synthesis – using the direct incorporation, precursor–pro-
duct approach – and breakdown – using the deuterated
water prelabeling approach – rates are determined by sim-
ilar intrasubject and intersubject coefficient of variation.
In comparison, the use of phenylalanine as representative
of any essential amino acid tracer for the FBR determina-
tion was not successful in the present setting, most likely
due to recycling, and hence, more work is required to
reveal whether such approach may be feasible. Further,
the application of the prelabeling approach to investigate
the fractional breakdown rate of a protein pool with a
complex post-translational modification and maturation
process, exemplified by the tendinous collagen protein,
revealed nonsense enrichments in our setup. This suggests
that when multiple pools of protein with very different
turnover rates exist, most likely due to the complex matu-
ration processes, variation in prelabeling and/or label-dis-
appearance kinetics are too divergent and the loss of
prelabeling in a matrix homogenate is not homogenous.
Although repeated tracer infusions also indicate divergent
turnover rates in myofibrillar proteins, the complexity of
collagenous protein matrices may be higher, and there-
fore, more work must be performed to reveal whether the
FBR approach can be applied on such tissues before being
applied. Therefore, we recommend that when the FBR of
protein fractions from other proteins/tissues and even
from different species (in vivo or in vitro) is measured,
evidence for its applicability should be demonstrated.
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